Medical strike ends as Punjab declares health emergency
All intermediate and practical examinations scheduled for the day were cancelled by the Punjab Boards, including the Part-II Islamiyat and Accounting papers. Matriculation practical exams across all boards were also postponed. Colleges and universities suspended their semester exams, with new dates to be announced once the institutions reopen.
The Punjab Health Department has directed all public hospitalsincluding District Headquarters (DHQs) and Tehsil Headquarters (THQs)to operate on a 24-hour emergency footing.
Senior medical staff, including professors, doctors, nurses, and paramedics, were ordered to remain on duty without exception.
In a significant development, the Grand Health Alliance, which had been on strike for over a month, suspended all protests and resumed duties to support emergency preparedness. Their return marks a unified response from the medical community amid heightened national tensions.
A high-level security and preparedness meeting was convened at Lahore General Hospital (LGH), chaired by Prof Al-Fareed Zafar, Principal of Ameer Uddin Medical College and PGMI.
The meeting was attended by senior faculty, administrative doctors, and hospital officials, including LGH Medical Superintendent Prof Dr Faryad Hussain and Dr. Umar Ishaq, MS of Punjab Institute of Neurosciences (PINS). Prof Zafar placed all LGH departments on high alert and appointed Prof. Armghan Israr Mirza as Director of Disaster Management to lead coordination across departments.
Detailed briefings were held with each department to ensure readiness, with special emphasis on emergency supplies, availability of life-saving drugs, standby ambulances, functional operation theatres and uninterrupted power backup.
Medical personnel were instructed to remain available at all times with their phones switched on and were prohibited from leaving their posts without prior approval.
Coordination was also established with the Blood Donation Society of AMC to guarantee timely supply of blood during any mass casualty event.
Reinforcing the need for discipline and national unity, Prof. Al-Fareed Zafar stated, "The country is in safe hands, and our Armed Forces have the full support of the nation. As medical professionals, we stand ready to work on the front lines around the clock, offering our services without hesitation in this critical time."
He praised the nation's resilience and urged the medical community to uphold their responsibilities with dedication and professionalism.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
11 hours ago
- Business Recorder
India's Apollo Hospitals beats estimates for Q1 profit on strong demand
HYDERABAD: India's Apollo Hospitals Enterprise on Tuesday reported its fifth straight quarterly profit rise, beating analysts' estimates on higher demand for its healthcare services. The hospital chain operator reported a consolidated net profit that rose 41.8% to 4.33 billion rupees ($49.40 million) for the April-June quarter. Analysts, on average, had expected of 3.86 billion rupees, according to data compiled by LSEG. Indian hospital chains such as Apollo and Manipal have been increasing their bed count for a larger share of the market, including through acquisitions of smaller hospital operators. Temasek-backed Manipal acquired a majority stake in local peer Sahyadri Hospitals last month. Apollo said it is on track to add 4,370 beds over the next 3-4 years through acquisition, setting up new hospitals, aswell as expansion of existing facilities. The hospital operator had 8,030 operational beds as of June 30. Occupancy rate for the quarter, however, saw a slight dip to 65% from 68% last year. Total revenue for the first quarter rose 15% to 58.42 billion rupees beating estimates of 57.44 billion rupees, aided by a 12% growth in the healthcare services business that contributes more than half of the total revenue. The company expects double-digit revenue growth for the current financial year. Its offline pharmacy and digital healthcare business reported a 19% rise in revenue. Apollo spun off the business recently and aims to list it as a separate entity in the next 18-21 months.
Express Tribune
a day ago
- Express Tribune
Genetic disorders drive childhood blindness in Pakistan
Listen to article Hereditary and congenital disorders account for an estimated 40 to 60 per cent of childhood blindness cases in Pakistan, according to new findings from Al-Shifa Trust Eye Hospital. Experts warn that the widespread lack of early genetic diagnosis leaves many children permanently blind, imposing a long-term health and economic burden on families and the national healthcare system. The data originates from Pakistan's first Department of Ophthalmic Genetics, where molecular geneticist Dr Rutaba and a dedicated bioinformatician are decoding complex DNA mutations linked to severe paediatric eye diseases. Their work has uncovered previously undocumented gene mutations associated with retinal degeneration, childhood cataracts and optic nerve abnormalities. 'Our goal is to identify the genetic root of each case and guide families on future risks,' said senior consultant and head of the Oculoplastic Department, Dr Tayyab Afghani. Read More: When the body turns on itself He emphasised that while global advances in gene therapy offer hope, most hereditary eye conditions remain incurable, making early diagnosis and counselling essential. Specialists at Al-Shifa emphasise that the impact of childhood vision loss extends far beyond the individual. Children with undiagnosed genetic eye conditions often face delayed schooling, limited mobility and social isolation, factors that compound over time to restrict their economic potential. In rural areas, where access to specialised care is even more limited, families frequently rely on informal remedies or remain unaware that the condition may be inherited and preventable. In Pakistan, where marriages within the family are common, the risk of inherited disorders is significantly higher. However, genetic testing is virtually unavailable in public hospitals due to a lack of laboratory infrastructure and trained personnel. Consequently, many children receive a diagnosis only after irreversible vision loss, affecting their education and future productivity. Also Read: A mirror to the nation's young To address this gap, Al-Shifa Trust now offers free genetic testing for patients referred through its hospital network, a service that typically costs around Rs100,000 per person. Since the department was launched, it has analysed a select group of complex cases - each requiring intensive DNA sequencing - to identify hereditary patterns and build a growing national genetic database. Al-Shifa Trust urges families with children suffering unexplained or congenital vision problems to seek evaluation promptly. Early genetic diagnosis not only improves clinical outcomes but also reduces the long-term financial and emotional toll of blindness on individuals and society.
Business Recorder
05-07-2025
- Business Recorder
Medicines that hinder rather than help healing
EDITORIAL: The report that about one-fifth of generic medicines' samples tested by researchers at the University of Notre Dame failed quality control tests is deeply troubling — all the more so given an increasing public reliance on generic drugs for affordable healthcare. Adding a further layer of concern is the finding that 16 of the 17 manufactures investigated are based in India, which plays a dominant role in global pharmaceutical supply chain. Often described as 'pharmacy of the world' the country produces approximately 20 percent of the generic medicines, exporting them to more than 100 countries. A vast majority of them are low and middle income ones, including Pakistan, raising red flags about the quality of medications being consumed. The drugs in questions, reveals the present report, form the backbone of treatment plans for numerous common cancers — including breast, ovarian and leukaemia. Some of them contained so little of their key ingredients that giving them to patients would be as good as doing nothing; other drugs in this category were composed of excessive active ingredients that put patients at risk of severe organ damage, even death. These findings suggest cost-efficiency is prioritised at the expense of quality assurance and regulatory compliance, and call into question reliability of existing regulatory frameworks both in the exporting and importing countries. In India, while there are regulations in place under the Central Drugs Standard Control Organisation, enforcement has been inconsistent, if not shoddy. Consequently, quality control lapses have plagued the sector for years. In 2023, Indian-made cough syrups made the news for causing death of at least 70 children in Gambia and many more in Cameroon and Uzbekistan. In August of last year, more than 50 drugs on the market, including some anti-acids and paracetamol, turned out to be substandard or fake. Much before that in 2013, Indian manufacturer Ranbaxy paid a fine of US$ 500 million after its US subsidiary pleaded guilty to improper manufacturing, storing and testing of drugs. These examples plus the research findings of University of Notre Dame underscore the need for regulatory review and response from Pakistan. Our health authorities, particularly the Drug Regulatory Authority of Pakistan (DRAP), must ramp up their quality assurance mechanisms, including more rigorous testing of imported drugs and reassessing licensing agreements with suspect companies. As regards the broader issue of accountability and transparency, those involved in producing substandard medicines must be made to face meaningful consequences, such as bans, fines and blacklisting from markets. While affordable medicines are crucial, they must not come at the cost of safety and efficacy; patients everywhere deserve better than to be exposed to life-threatening risks from bad medications. Governments and regulators need to act decisively to certify that each medicine contains everything that is stated on its label. Copyright Business Recorder, 2025
